instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema multiforme'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Laryngeal pain'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Laryngitis'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Non-cardiac chest pain'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Obstruction gastric'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophageal obstruction'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophageal pain'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophagitis'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oropharyngeal pain'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral sensory neuropathy'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pharyngitis'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pigmentation disorder'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Radiation skin injury'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stoma site infection'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stomatitis'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight decreased'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
What was the administration route of drug 'CAPECITABINE'? | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Unilateral abdominal clonic jerking as an epileptic phenomenon.
Unilateral abdominal wall clonic seizures are a rare manifestation of epilepsy. We report three cases of focal aware seizures manifesting as unilateral abdominal clonic motor movements. Standard EEG for patients with focal motor abdominal seizures is often... | VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34647004 | 20,438,260 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.
The definitive efficacy of anaplastic lymphoma kinase (ALK) inhibitors in ALK positive lung squamous cell carcinoma (sqCC) patients remain unclear. Here, we report a case in which brigatinib had a therapeutic effect o... | CARBOPLATIN, GEMCITABINE | DrugsGivenReaction | CC BY | 34647426 | 20,852,978 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.
The definitive efficacy of anaplastic lymphoma kinase (ALK) inhibitors in ALK positive lung squamous cell carcinoma (sqCC) patients remain unclear. Here, we report a case in which brigatinib had a therapeutic effect o... | CARBOPLATIN, GEMCITABINE | DrugsGivenReaction | CC BY | 34647426 | 20,852,978 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.
The definitive efficacy of anaplastic lymphoma kinase (ALK) inhibitors in ALK positive lung squamous cell carcinoma (sqCC) patients remain unclear. Here, we report a case in which brigatinib had a therapeutic effect o... | CARBOPLATIN, GEMCITABINE | DrugsGivenReaction | CC BY | 34647426 | 20,852,978 | 2021-12 |
What was the dosage of drug 'CARBOPLATIN'? | Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.
The definitive efficacy of anaplastic lymphoma kinase (ALK) inhibitors in ALK positive lung squamous cell carcinoma (sqCC) patients remain unclear. Here, we report a case in which brigatinib had a therapeutic effect o... | UNK (AUC5 D2, PER 21 DAYS) | DrugDosageText | CC BY | 34647426 | 20,852,978 | 2021-12 |
What was the dosage of drug 'GEMCITABINE'? | Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.
The definitive efficacy of anaplastic lymphoma kinase (ALK) inhibitors in ALK positive lung squamous cell carcinoma (sqCC) patients remain unclear. Here, we report a case in which brigatinib had a therapeutic effect o... | UNK (1250 MG/M2 D1, D8) | DrugDosageText | CC BY | 34647426 | 20,852,978 | 2021-12 |
What was the outcome of reaction 'Fatigue'? | Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.
The definitive efficacy of anaplastic lymphoma kinase (ALK) inhibitors in ALK positive lung squamous cell carcinoma (sqCC) patients remain unclear. Here, we report a case in which brigatinib had a therapeutic effect o... | Recovered | ReactionOutcome | CC BY | 34647426 | 20,852,978 | 2021-12 |
What was the outcome of reaction 'Myelosuppression'? | Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.
The definitive efficacy of anaplastic lymphoma kinase (ALK) inhibitors in ALK positive lung squamous cell carcinoma (sqCC) patients remain unclear. Here, we report a case in which brigatinib had a therapeutic effect o... | Recovered | ReactionOutcome | CC BY | 34647426 | 20,852,978 | 2021-12 |
What was the outcome of reaction 'Nausea'? | Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.
The definitive efficacy of anaplastic lymphoma kinase (ALK) inhibitors in ALK positive lung squamous cell carcinoma (sqCC) patients remain unclear. Here, we report a case in which brigatinib had a therapeutic effect o... | Recovered | ReactionOutcome | CC BY | 34647426 | 20,852,978 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Thrombotic microangiopathy associated with arboviral infection: Report of 3 cases.
Dengue fever and chikungunya are viral diseases that have spread rapidly throughout the world in recent decades. The occurrence of complications is well known, including prerenal acute kidney injury (AKI), which is usually thought to be ... | ECULIZUMAB | DrugsGivenReaction | CC BY | 34648498 | 19,985,945 | 2021-10 |
What was the outcome of reaction 'Acute kidney injury'? | Thrombotic microangiopathy associated with arboviral infection: Report of 3 cases.
Dengue fever and chikungunya are viral diseases that have spread rapidly throughout the world in recent decades. The occurrence of complications is well known, including prerenal acute kidney injury (AKI), which is usually thought to be ... | Recovered | ReactionOutcome | CC BY | 34648498 | 19,985,945 | 2021-10 |
What was the outcome of reaction 'Pneumatosis intestinalis'? | Two case reports of pneumatosis intestinalis in patients with cancer: is surgical management mandatory?
Pneumatosis intestinalis (PI) can be classified into two groups. Primary PI is idiopathic, and patients can recover spontaneously. In contrast, secondary PI is considered fatal due to the high mortality rate associat... | Recovered | ReactionOutcome | CC BY-NC | 34649412 | 20,168,702 | 2021-09 |
What was the outcome of reaction 'Pneumoperitoneum'? | Two case reports of pneumatosis intestinalis in patients with cancer: is surgical management mandatory?
Pneumatosis intestinalis (PI) can be classified into two groups. Primary PI is idiopathic, and patients can recover spontaneously. In contrast, secondary PI is considered fatal due to the high mortality rate associat... | Recovered | ReactionOutcome | CC BY-NC | 34649412 | 20,168,702 | 2021-09 |
What is the weight of the patient? | A case series of pediatric COVID-19 with complicated symptoms in Iran.
People in different age groups are susceptible to SARS-CoV-2 infection as a newly emerging virus. However, the clinical course, symptoms and disease outcome vary from case to case. Although COVID-19 is usually milder in children than adults, some st... | 3 kg. | Weight | CC BY | 34650617 | 20,553,996 | 2021-09 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | A case series of pediatric COVID-19 with complicated symptoms in Iran.
People in different age groups are susceptible to SARS-CoV-2 infection as a newly emerging virus. However, the clinical course, symptoms and disease outcome vary from case to case. Although COVID-19 is usually milder in children than adults, some st... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34650617 | 20,546,327 | 2021-09 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | A case series of pediatric COVID-19 with complicated symptoms in Iran.
People in different age groups are susceptible to SARS-CoV-2 infection as a newly emerging virus. However, the clinical course, symptoms and disease outcome vary from case to case. Although COVID-19 is usually milder in children than adults, some st... | Fatal | ReactionOutcome | CC BY | 34650617 | 20,542,805 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adrenal haemorrhage'. | The role of vitamin K in the non-operative management of bilateral adrenal hemorrhage on a background of antiphospholipid syndrome and coagulopathy: a case report.
Bilateral adrenal hemorrhage (BAH) is a rare condition, which can easily become a serious threat to life. It is even rarer in the setting of antiphospholipi... | GENTAMICIN, TEMOCILLIN, WARFARIN | DrugsGivenReaction | CC BY-NC | 34650790 | 20,516,166 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adrenal insufficiency'. | The role of vitamin K in the non-operative management of bilateral adrenal hemorrhage on a background of antiphospholipid syndrome and coagulopathy: a case report.
Bilateral adrenal hemorrhage (BAH) is a rare condition, which can easily become a serious threat to life. It is even rarer in the setting of antiphospholipi... | GENTAMICIN, TEMOCILLIN, WARFARIN | DrugsGivenReaction | CC BY-NC | 34650790 | 20,516,166 | 2021-10 |
What was the administration route of drug 'GENTAMICIN'? | The role of vitamin K in the non-operative management of bilateral adrenal hemorrhage on a background of antiphospholipid syndrome and coagulopathy: a case report.
Bilateral adrenal hemorrhage (BAH) is a rare condition, which can easily become a serious threat to life. It is even rarer in the setting of antiphospholipi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34650790 | 20,516,166 | 2021-10 |
What was the administration route of drug 'TEMOCILLIN'? | The role of vitamin K in the non-operative management of bilateral adrenal hemorrhage on a background of antiphospholipid syndrome and coagulopathy: a case report.
Bilateral adrenal hemorrhage (BAH) is a rare condition, which can easily become a serious threat to life. It is even rarer in the setting of antiphospholipi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34650790 | 20,516,166 | 2021-10 |
What was the outcome of reaction 'Adrenal haemorrhage'? | The role of vitamin K in the non-operative management of bilateral adrenal hemorrhage on a background of antiphospholipid syndrome and coagulopathy: a case report.
Bilateral adrenal hemorrhage (BAH) is a rare condition, which can easily become a serious threat to life. It is even rarer in the setting of antiphospholipi... | Recovered | ReactionOutcome | CC BY-NC | 34650790 | 20,516,166 | 2021-10 |
What was the outcome of reaction 'Adrenal insufficiency'? | The role of vitamin K in the non-operative management of bilateral adrenal hemorrhage on a background of antiphospholipid syndrome and coagulopathy: a case report.
Bilateral adrenal hemorrhage (BAH) is a rare condition, which can easily become a serious threat to life. It is even rarer in the setting of antiphospholipi... | Recovering | ReactionOutcome | CC BY-NC | 34650790 | 20,516,166 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Complete response of MSI-high metastatic colon cancer following treatment with regorafenib: A case report.
Regorafenib has been demonstrated to prolong survival in patients with metastatic colorectal cancer refractory to standard chemotherapy. However, overall survival is limited to 2.5 months. The present report descr... | BEVACIZUMAB, CETUXIMAB, FLUOROURACIL, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34650810 | 20,099,660 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Complete response of MSI-high metastatic colon cancer following treatment with regorafenib: A case report.
Regorafenib has been demonstrated to prolong survival in patients with metastatic colorectal cancer refractory to standard chemotherapy. However, overall survival is limited to 2.5 months. The present report descr... | BEVACIZUMAB, CETUXIMAB, FLUOROURACIL, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34650810 | 20,099,660 | 2021-11 |
What was the dosage of drug 'IRINOTECAN'? | Complete response of MSI-high metastatic colon cancer following treatment with regorafenib: A case report.
Regorafenib has been demonstrated to prolong survival in patients with metastatic colorectal cancer refractory to standard chemotherapy. However, overall survival is limited to 2.5 months. The present report descr... | UNK, FOLFIRI | DrugDosageText | CC BY-NC-ND | 34650810 | 20,099,660 | 2021-11 |
What was the dosage of drug 'OXALIPLATIN'? | Complete response of MSI-high metastatic colon cancer following treatment with regorafenib: A case report.
Regorafenib has been demonstrated to prolong survival in patients with metastatic colorectal cancer refractory to standard chemotherapy. However, overall survival is limited to 2.5 months. The present report descr... | UNK,FOLFOX | DrugDosageText | CC BY-NC-ND | 34650810 | 20,099,660 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug eruption'. | Spironolactone-Induced Lichenoid Drug Reaction and Subsequent Diffuse Eruptive Squamous Cell Carcinomas Successfully Treated With Systemic Methotrexate.
Antihypertensive agents such as spironolactone have been reported to cause lichenoid drug eruptions. Eruptive keratoacanthomas (KA), considered to be well-differentiat... | SPIRONOLACTONE | DrugsGivenReaction | CC BY | 34650887 | 20,012,750 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Keratoacanthoma'. | Spironolactone-Induced Lichenoid Drug Reaction and Subsequent Diffuse Eruptive Squamous Cell Carcinomas Successfully Treated With Systemic Methotrexate.
Antihypertensive agents such as spironolactone have been reported to cause lichenoid drug eruptions. Eruptive keratoacanthomas (KA), considered to be well-differentiat... | SPIRONOLACTONE | DrugsGivenReaction | CC BY | 34650887 | 20,012,750 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Squamous cell carcinoma'. | Spironolactone-Induced Lichenoid Drug Reaction and Subsequent Diffuse Eruptive Squamous Cell Carcinomas Successfully Treated With Systemic Methotrexate.
Antihypertensive agents such as spironolactone have been reported to cause lichenoid drug eruptions. Eruptive keratoacanthomas (KA), considered to be well-differentiat... | SPIRONOLACTONE | DrugsGivenReaction | CC BY | 34650887 | 20,012,750 | 2021-09 |
What was the dosage of drug 'SPIRONOLACTONE'? | Spironolactone-Induced Lichenoid Drug Reaction and Subsequent Diffuse Eruptive Squamous Cell Carcinomas Successfully Treated With Systemic Methotrexate.
Antihypertensive agents such as spironolactone have been reported to cause lichenoid drug eruptions. Eruptive keratoacanthomas (KA), considered to be well-differentiat... | 50 mg (milligrams). | DrugDosage | CC BY | 34650887 | 20,012,750 | 2021-09 |
What was the outcome of reaction 'Drug eruption'? | Spironolactone-Induced Lichenoid Drug Reaction and Subsequent Diffuse Eruptive Squamous Cell Carcinomas Successfully Treated With Systemic Methotrexate.
Antihypertensive agents such as spironolactone have been reported to cause lichenoid drug eruptions. Eruptive keratoacanthomas (KA), considered to be well-differentiat... | Recovered | ReactionOutcome | CC BY | 34650887 | 20,012,750 | 2021-09 |
What was the outcome of reaction 'Keratoacanthoma'? | Spironolactone-Induced Lichenoid Drug Reaction and Subsequent Diffuse Eruptive Squamous Cell Carcinomas Successfully Treated With Systemic Methotrexate.
Antihypertensive agents such as spironolactone have been reported to cause lichenoid drug eruptions. Eruptive keratoacanthomas (KA), considered to be well-differentiat... | Recovered | ReactionOutcome | CC BY | 34650887 | 20,012,750 | 2021-09 |
What was the outcome of reaction 'Squamous cell carcinoma'? | Spironolactone-Induced Lichenoid Drug Reaction and Subsequent Diffuse Eruptive Squamous Cell Carcinomas Successfully Treated With Systemic Methotrexate.
Antihypertensive agents such as spironolactone have been reported to cause lichenoid drug eruptions. Eruptive keratoacanthomas (KA), considered to be well-differentiat... | Recovered | ReactionOutcome | CC BY | 34650887 | 20,012,750 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatotoxicity'. | Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature.
Since their license in 2008, studies on thrombopoietin receptor agonists (TPO-RAs) are proceeding at a fast pace. Their favorable efficacy and safety profile makes them good candidates for the management of thrombocytopenia in ... | ELTROMBOPAG | DrugsGivenReaction | CC BY | 34650908 | 20,142,357 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature.
Since their license in 2008, studies on thrombopoietin receptor agonists (TPO-RAs) are proceeding at a fast pace. Their favorable efficacy and safety profile makes them good candidates for the management of thrombocytopenia in ... | ELTROMBOPAG | DrugsGivenReaction | CC BY | 34650908 | 20,142,357 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature.
Since their license in 2008, studies on thrombopoietin receptor agonists (TPO-RAs) are proceeding at a fast pace. Their favorable efficacy and safety profile makes them good candidates for the management of thrombocytopenia in ... | ELTROMBOPAG | DrugsGivenReaction | CC BY | 34650908 | 20,142,357 | 2021 |
What was the outcome of reaction 'Hepatotoxicity'? | Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature.
Since their license in 2008, studies on thrombopoietin receptor agonists (TPO-RAs) are proceeding at a fast pace. Their favorable efficacy and safety profile makes them good candidates for the management of thrombocytopenia in ... | Recovered | ReactionOutcome | CC BY | 34650908 | 20,142,357 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic kidney disease'. | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, THALIDOMIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Glomerulonephritis membranoproliferative'. | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, THALIDOMIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mesangioproliferative glomerulonephritis'. | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, THALIDOMIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyelonephritis acute'. | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, THALIDOMIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal tubular atrophy'. | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, THALIDOMIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, THALIDOMIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tubulointerstitial nephritis'. | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, THALIDOMIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
What was the administration route of drug 'THALIDOMIDE'? | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34651090 | 20,487,129 | 2021 |
What was the dosage of drug 'DEXAMETHASONE SODIUM PHOSPHATE'? | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | 10 CYCLICAL | DrugDosageText | CC BY-NC-ND | 34651090 | 20,061,110 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | ()CYCLICAL | DrugDosageText | CC BY-NC-ND | 34651090 | 20,487,129 | 2021 |
What was the outcome of reaction 'Chronic kidney disease'? | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | Recovering | ReactionOutcome | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
What was the outcome of reaction 'Renal tubular atrophy'? | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | Recovering | ReactionOutcome | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
What was the outcome of reaction 'Toxicity to various agents'? | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | Recovering | ReactionOutcome | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
What was the outcome of reaction 'Tubulointerstitial nephritis'? | IgA nephropathy in IgG kappa multiple myeloma.
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studi... | Recovering | ReactionOutcome | CC BY-NC-ND | 34651090 | 20,206,306 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | BRCA1 Reversion Mutation Confers Resistance to Olaparib and Camrelizumab in a Patient with Breast Cancer Liver Metastasis.
Reversion mutations are associated with clinical resistance to poly(ADP-ribose) polymerase inhibitors (PARPi). Here, we describe the detection of a BRCA1 reversion mutation in a 39-year-old woman w... | ANASTROZOLE, GOSERELIN, PALBOCICLIB | DrugsGivenReaction | CC BY-NC | 34652076 | 20,263,725 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Suicide attempt induced by drug-induced leukoencephalopathy: A case report.
BACKGROUND
Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempt... | BROTIZOLAM, CYCLOPHOSPHAMIDE, DOXORUBICIN, METHOTREXATE, PREDNISOLONE, PROCARBAZINE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34652886 | 20,078,903 | 2021-10-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Altered state of consciousness'. | Suicide attempt induced by drug-induced leukoencephalopathy: A case report.
BACKGROUND
Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempt... | BROTIZOLAM, CYCLOPHOSPHAMIDE, DOXORUBICIN, METHOTREXATE, PREDNISOLONE, PROCARBAZINE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34652886 | 20,078,903 | 2021-10-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Insomnia'. | Suicide attempt induced by drug-induced leukoencephalopathy: A case report.
BACKGROUND
Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempt... | CYCLOPHOSPHAMIDE, DOXORUBICIN, METHOTREXATE, PREDNISOLONE, PROCARBAZINE, RITUXIMAB, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-ND | 34652886 | 20,006,727 | 2021-10-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Restlessness'. | Suicide attempt induced by drug-induced leukoencephalopathy: A case report.
BACKGROUND
Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempt... | BROTIZOLAM, CYCLOPHOSPHAMIDE, DOXORUBICIN, METHOTREXATE, PREDNISOLONE, PROCARBAZINE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34652886 | 20,078,903 | 2021-10-15 |
What was the dosage of drug 'BROTIZOLAM'? | Suicide attempt induced by drug-induced leukoencephalopathy: A case report.
BACKGROUND
Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempt... | 0.25 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34652886 | 20,078,903 | 2021-10-15 |
What was the dosage of drug 'METHOTREXATE SODIUM'? | Suicide attempt induced by drug-induced leukoencephalopathy: A case report.
BACKGROUND
Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempt... | UNK, CYCLIC (HIGH DOSE) | DrugDosageText | CC BY-NC-ND | 34652886 | 20,009,119 | 2021-10-15 |
What was the outcome of reaction 'Insomnia'? | Suicide attempt induced by drug-induced leukoencephalopathy: A case report.
BACKGROUND
Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempt... | Recovering | ReactionOutcome | CC BY-NC-ND | 34652886 | 20,006,727 | 2021-10-15 |
What was the outcome of reaction 'Leukoencephalopathy'? | Suicide attempt induced by drug-induced leukoencephalopathy: A case report.
BACKGROUND
Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempt... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34652886 | 20,050,004 | 2021-10-15 |
What was the outcome of reaction 'Suicide attempt'? | Suicide attempt induced by drug-induced leukoencephalopathy: A case report.
BACKGROUND
Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempt... | Recovered | ReactionOutcome | CC BY-NC-ND | 34652886 | 20,035,199 | 2021-10-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Brain oedema'. | Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD.
Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is associated with numerous adverse outcomes. Patients with schizophrenia are particularly susceptible to hyponatraemia, in part due to the close association... | ASPIRIN, LEVOTHYROXINE, METFORMIN HYDROCHLORIDE, QUETIAPINE FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 34653996 | 19,429,433 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD.
Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is associated with numerous adverse outcomes. Patients with schizophrenia are particularly susceptible to hyponatraemia, in part due to the close association... | ASPIRIN, LEVOTHYROXINE, METFORMIN HYDROCHLORIDE, QUETIAPINE FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 34653996 | 19,429,433 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Inappropriate antidiuretic hormone secretion'. | Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD.
Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is associated with numerous adverse outcomes. Patients with schizophrenia are particularly susceptible to hyponatraemia, in part due to the close association... | ASPIRIN, LEVOTHYROXINE, METFORMIN HYDROCHLORIDE, QUETIAPINE FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 34653996 | 19,429,433 | 2021-10-01 |
What was the administration route of drug 'QUETIAPINE FUMARATE'? | Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD.
Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is associated with numerous adverse outcomes. Patients with schizophrenia are particularly susceptible to hyponatraemia, in part due to the close association... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34653996 | 19,429,433 | 2021-10-01 |
What was the dosage of drug 'ASPIRIN'? | Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD.
Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is associated with numerous adverse outcomes. Patients with schizophrenia are particularly susceptible to hyponatraemia, in part due to the close association... | 75 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34653996 | 19,429,433 | 2021-10-01 |
What was the dosage of drug 'LEVOTHYROXINE'? | Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD.
Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is associated with numerous adverse outcomes. Patients with schizophrenia are particularly susceptible to hyponatraemia, in part due to the close association... | 175 µg (micrograms). | DrugDosage | CC BY-NC-ND | 34653996 | 19,429,433 | 2021-10-01 |
What was the dosage of drug 'QUETIAPINE FUMARATE'? | Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD.
Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is associated with numerous adverse outcomes. Patients with schizophrenia are particularly susceptible to hyponatraemia, in part due to the close association... | 300 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34653996 | 19,429,433 | 2021-10-01 |
What was the outcome of reaction 'Brain oedema'? | Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD.
Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is associated with numerous adverse outcomes. Patients with schizophrenia are particularly susceptible to hyponatraemia, in part due to the close association... | Recovered | ReactionOutcome | CC BY-NC-ND | 34653996 | 19,429,433 | 2021-10-01 |
What was the outcome of reaction 'Hyponatraemia'? | Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD.
Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is associated with numerous adverse outcomes. Patients with schizophrenia are particularly susceptible to hyponatraemia, in part due to the close association... | Recovered | ReactionOutcome | CC BY-NC-ND | 34653996 | 19,429,433 | 2021-10-01 |
What was the outcome of reaction 'Inappropriate antidiuretic hormone secretion'? | Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD.
Hyponatraemia is the most common electrolyte disturbance in hospitalised patients and is associated with numerous adverse outcomes. Patients with schizophrenia are particularly susceptible to hyponatraemia, in part due to the close association... | Recovered | ReactionOutcome | CC BY-NC-ND | 34653996 | 19,429,433 | 2021-10-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoaesthesia'. | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | ATORVASTATIN, HYDROCHLOROTHIAZIDE\LISINOPRIL, INSULIN DEGLUDEC, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34654335 | 20,078,145 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Loss of personal independence in daily activities'. | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | ATORVASTATIN, HYDROCHLOROTHIAZIDE\LISINOPRIL, INSULIN DEGLUDEC, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34654335 | 20,164,389 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscular weakness'. | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | ATORVASTATIN, HYDROCHLOROTHIAZIDE\LISINOPRIL, INSULIN DEGLUDEC, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34654335 | 20,078,145 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraesthesia'. | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | ATORVASTATIN, HYDROCHLOROTHIAZIDE\LISINOPRIL, INSULIN DEGLUDEC, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34654335 | 20,078,145 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral motor neuropathy'. | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | ATORVASTATIN, HYDROCHLOROTHIAZIDE\LISINOPRIL, INSULIN DEGLUDEC, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34654335 | 20,164,389 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.